Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations

Multiple theories have been proposed describing the pathogenic mechanisms of ( )-associated gastric motility disorders. We assessed ex vivo pyloric activity in -infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: Gastrointestinal and liver physiology 2021-11, Vol.321 (5), p.G461-G476
Hauptverfasser: Ashraf, Aya Aly, Gamal, Sarah Mahmoud, Ashour, Hend, Aboulhoda, Basma Emad, Rashed, Laila Ahmed, Harb, Inas Anas, Abdelfattah, Gaber Hassan, El-Seidi, Eman Ahmed, Shawky, Heba Mohamed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page G476
container_issue 5
container_start_page G461
container_title American journal of physiology: Gastrointestinal and liver physiology
container_volume 321
creator Ashraf, Aya Aly
Gamal, Sarah Mahmoud
Ashour, Hend
Aboulhoda, Basma Emad
Rashed, Laila Ahmed
Harb, Inas Anas
Abdelfattah, Gaber Hassan
El-Seidi, Eman Ahmed
Shawky, Heba Mohamed
description Multiple theories have been proposed describing the pathogenic mechanisms of ( )-associated gastric motility disorders. We assessed ex vivo pyloric activity in -infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups: ) control group, ) sterile broth (vehicle group), ) amoxicillin control, ) omeperazole control, ) clarithromycin control, ) triple therapy control, ) - group, ) -clarithromycin group, and ) -triple therapy group. Urease enzyme activity was applied as an indicator of infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By infection, a significant ( < 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased ( < 0.001) in the infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion, infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in -associated pyloric dysfunction, which might help in the management of human manifestations and complications. This work is investigating functional, histopathological, and molecular changes underlying hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to infection-associated hypomotility. infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.
doi_str_mv 10.1152/ajpgi.00364.2020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2593905555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2593905555</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-b9e0f0f2386dba043c28fe151e47598df6e5d13050968c6dadedb8e78880c1613</originalsourceid><addsrcrecordid>eNpdkUFP3DAQRq2qCBbKvScUqRcOZDuO7azTG0ItICFxac-RY08Wr5w4tR2k_fc4sHBgLqMZvfmk0SPkO4U1paL6qXbT1q4BWM3XFVTwhazyuiqp4JuvZAW0YSWVYnNCTmPcAYCoKD0mJ4xzRjmIFUn34zPGZLcq2XFb3KGz2ndKJwzFtHc-2KIM6FRCc5h18bSf_OCTdTbtfxX9POpk_ajcVfFkY_LOb61eJjWaYvAO9exUKJTLmWoh4zdy1CsX8fzQz8i_P7__3tyVD4-39zfXD6WuJKSyaxB66Csma9Mp4Cyve6SCIt-IRpq-RmEoAwFNLXVtlEHTSdxIKUHTmrIzcvmWOwX_f85vtoONGp1TI_o5tpWoOW8Aasjoj0_ozs8hP7VQDWtA5MoUvFE6-BgD9u0U7KDCvqXQLkbaVyPtq5F2MZJPLg7Bczeg-Th4V8BeAEHviZk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2593905555</pqid></control><display><type>article</type><title>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Ashraf, Aya Aly ; Gamal, Sarah Mahmoud ; Ashour, Hend ; Aboulhoda, Basma Emad ; Rashed, Laila Ahmed ; Harb, Inas Anas ; Abdelfattah, Gaber Hassan ; El-Seidi, Eman Ahmed ; Shawky, Heba Mohamed</creator><creatorcontrib>Ashraf, Aya Aly ; Gamal, Sarah Mahmoud ; Ashour, Hend ; Aboulhoda, Basma Emad ; Rashed, Laila Ahmed ; Harb, Inas Anas ; Abdelfattah, Gaber Hassan ; El-Seidi, Eman Ahmed ; Shawky, Heba Mohamed</creatorcontrib><description>Multiple theories have been proposed describing the pathogenic mechanisms of ( )-associated gastric motility disorders. We assessed ex vivo pyloric activity in -infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups: ) control group, ) sterile broth (vehicle group), ) amoxicillin control, ) omeperazole control, ) clarithromycin control, ) triple therapy control, ) - group, ) -clarithromycin group, and ) -triple therapy group. Urease enzyme activity was applied as an indicator of infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By infection, a significant ( &lt; 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased ( &lt; 0.001) in the infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion, infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in -associated pyloric dysfunction, which might help in the management of human manifestations and complications. This work is investigating functional, histopathological, and molecular changes underlying hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to infection-associated hypomotility. infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.</description><identifier>ISSN: 0193-1857</identifier><identifier>EISSN: 1522-1547</identifier><identifier>DOI: 10.1152/ajpgi.00364.2020</identifier><identifier>PMID: 34431405</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Actin ; Actins - metabolism ; Amoxicillin ; Animals ; Anti-Bacterial Agents - pharmacology ; Cadherins - metabolism ; Clarithromycin ; Disease Models, Animal ; Drug Therapy, Combination ; E-cadherin ; Enzymatic activity ; Epithelial-Mesenchymal Transition - drug effects ; Gastric motility ; Gastrointestinal Motility - drug effects ; Ghrelin ; Ghrelin - blood ; Helicobacter Infections - drug therapy ; Helicobacter Infections - metabolism ; Helicobacter Infections - microbiology ; Helicobacter Infections - physiopathology ; Helicobacter pylori ; Helicobacter pylori - pathogenicity ; Infections ; Male ; Mesenchyme ; MicroRNAs - genetics ; MicroRNAs - metabolism ; Muscle contraction ; Muscle, Smooth - drug effects ; Muscle, Smooth - metabolism ; Muscle, Smooth - microbiology ; Muscle, Smooth - physiopathology ; Proton Pump Inhibitors - pharmacology ; Pyloric muscle ; Pylorus - drug effects ; Pylorus - metabolism ; Pylorus - microbiology ; Pylorus - physiopathology ; Rats ; Rats, Wistar ; Smooth muscle ; Stomach Diseases - drug therapy ; Stomach Diseases - metabolism ; Stomach Diseases - microbiology ; Stomach Diseases - physiopathology ; Transforming Growth Factor beta - metabolism ; Transforming growth factor-b ; Urease</subject><ispartof>American journal of physiology: Gastrointestinal and liver physiology, 2021-11, Vol.321 (5), p.G461-G476</ispartof><rights>Copyright American Physiological Society Nov 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c280t-b9e0f0f2386dba043c28fe151e47598df6e5d13050968c6dadedb8e78880c1613</cites><orcidid>0000-0001-9333-4509 ; 0000-0002-5423-7228</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34431405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ashraf, Aya Aly</creatorcontrib><creatorcontrib>Gamal, Sarah Mahmoud</creatorcontrib><creatorcontrib>Ashour, Hend</creatorcontrib><creatorcontrib>Aboulhoda, Basma Emad</creatorcontrib><creatorcontrib>Rashed, Laila Ahmed</creatorcontrib><creatorcontrib>Harb, Inas Anas</creatorcontrib><creatorcontrib>Abdelfattah, Gaber Hassan</creatorcontrib><creatorcontrib>El-Seidi, Eman Ahmed</creatorcontrib><creatorcontrib>Shawky, Heba Mohamed</creatorcontrib><title>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</title><title>American journal of physiology: Gastrointestinal and liver physiology</title><addtitle>Am J Physiol Gastrointest Liver Physiol</addtitle><description>Multiple theories have been proposed describing the pathogenic mechanisms of ( )-associated gastric motility disorders. We assessed ex vivo pyloric activity in -infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups: ) control group, ) sterile broth (vehicle group), ) amoxicillin control, ) omeperazole control, ) clarithromycin control, ) triple therapy control, ) - group, ) -clarithromycin group, and ) -triple therapy group. Urease enzyme activity was applied as an indicator of infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By infection, a significant ( &lt; 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased ( &lt; 0.001) in the infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion, infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in -associated pyloric dysfunction, which might help in the management of human manifestations and complications. This work is investigating functional, histopathological, and molecular changes underlying hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to infection-associated hypomotility. infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.</description><subject>Actin</subject><subject>Actins - metabolism</subject><subject>Amoxicillin</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Cadherins - metabolism</subject><subject>Clarithromycin</subject><subject>Disease Models, Animal</subject><subject>Drug Therapy, Combination</subject><subject>E-cadherin</subject><subject>Enzymatic activity</subject><subject>Epithelial-Mesenchymal Transition - drug effects</subject><subject>Gastric motility</subject><subject>Gastrointestinal Motility - drug effects</subject><subject>Ghrelin</subject><subject>Ghrelin - blood</subject><subject>Helicobacter Infections - drug therapy</subject><subject>Helicobacter Infections - metabolism</subject><subject>Helicobacter Infections - microbiology</subject><subject>Helicobacter Infections - physiopathology</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - pathogenicity</subject><subject>Infections</subject><subject>Male</subject><subject>Mesenchyme</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>Muscle contraction</subject><subject>Muscle, Smooth - drug effects</subject><subject>Muscle, Smooth - metabolism</subject><subject>Muscle, Smooth - microbiology</subject><subject>Muscle, Smooth - physiopathology</subject><subject>Proton Pump Inhibitors - pharmacology</subject><subject>Pyloric muscle</subject><subject>Pylorus - drug effects</subject><subject>Pylorus - metabolism</subject><subject>Pylorus - microbiology</subject><subject>Pylorus - physiopathology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Smooth muscle</subject><subject>Stomach Diseases - drug therapy</subject><subject>Stomach Diseases - metabolism</subject><subject>Stomach Diseases - microbiology</subject><subject>Stomach Diseases - physiopathology</subject><subject>Transforming Growth Factor beta - metabolism</subject><subject>Transforming growth factor-b</subject><subject>Urease</subject><issn>0193-1857</issn><issn>1522-1547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUFP3DAQRq2qCBbKvScUqRcOZDuO7azTG0ItICFxac-RY08Wr5w4tR2k_fc4sHBgLqMZvfmk0SPkO4U1paL6qXbT1q4BWM3XFVTwhazyuiqp4JuvZAW0YSWVYnNCTmPcAYCoKD0mJ4xzRjmIFUn34zPGZLcq2XFb3KGz2ndKJwzFtHc-2KIM6FRCc5h18bSf_OCTdTbtfxX9POpk_ajcVfFkY_LOb61eJjWaYvAO9exUKJTLmWoh4zdy1CsX8fzQz8i_P7__3tyVD4-39zfXD6WuJKSyaxB66Csma9Mp4Cyve6SCIt-IRpq-RmEoAwFNLXVtlEHTSdxIKUHTmrIzcvmWOwX_f85vtoONGp1TI_o5tpWoOW8Aasjoj0_ozs8hP7VQDWtA5MoUvFE6-BgD9u0U7KDCvqXQLkbaVyPtq5F2MZJPLg7Bczeg-Th4V8BeAEHviZk</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Ashraf, Aya Aly</creator><creator>Gamal, Sarah Mahmoud</creator><creator>Ashour, Hend</creator><creator>Aboulhoda, Basma Emad</creator><creator>Rashed, Laila Ahmed</creator><creator>Harb, Inas Anas</creator><creator>Abdelfattah, Gaber Hassan</creator><creator>El-Seidi, Eman Ahmed</creator><creator>Shawky, Heba Mohamed</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9333-4509</orcidid><orcidid>https://orcid.org/0000-0002-5423-7228</orcidid></search><sort><creationdate>20211101</creationdate><title>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</title><author>Ashraf, Aya Aly ; Gamal, Sarah Mahmoud ; Ashour, Hend ; Aboulhoda, Basma Emad ; Rashed, Laila Ahmed ; Harb, Inas Anas ; Abdelfattah, Gaber Hassan ; El-Seidi, Eman Ahmed ; Shawky, Heba Mohamed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-b9e0f0f2386dba043c28fe151e47598df6e5d13050968c6dadedb8e78880c1613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Actin</topic><topic>Actins - metabolism</topic><topic>Amoxicillin</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Cadherins - metabolism</topic><topic>Clarithromycin</topic><topic>Disease Models, Animal</topic><topic>Drug Therapy, Combination</topic><topic>E-cadherin</topic><topic>Enzymatic activity</topic><topic>Epithelial-Mesenchymal Transition - drug effects</topic><topic>Gastric motility</topic><topic>Gastrointestinal Motility - drug effects</topic><topic>Ghrelin</topic><topic>Ghrelin - blood</topic><topic>Helicobacter Infections - drug therapy</topic><topic>Helicobacter Infections - metabolism</topic><topic>Helicobacter Infections - microbiology</topic><topic>Helicobacter Infections - physiopathology</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - pathogenicity</topic><topic>Infections</topic><topic>Male</topic><topic>Mesenchyme</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>Muscle contraction</topic><topic>Muscle, Smooth - drug effects</topic><topic>Muscle, Smooth - metabolism</topic><topic>Muscle, Smooth - microbiology</topic><topic>Muscle, Smooth - physiopathology</topic><topic>Proton Pump Inhibitors - pharmacology</topic><topic>Pyloric muscle</topic><topic>Pylorus - drug effects</topic><topic>Pylorus - metabolism</topic><topic>Pylorus - microbiology</topic><topic>Pylorus - physiopathology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Smooth muscle</topic><topic>Stomach Diseases - drug therapy</topic><topic>Stomach Diseases - metabolism</topic><topic>Stomach Diseases - microbiology</topic><topic>Stomach Diseases - physiopathology</topic><topic>Transforming Growth Factor beta - metabolism</topic><topic>Transforming growth factor-b</topic><topic>Urease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ashraf, Aya Aly</creatorcontrib><creatorcontrib>Gamal, Sarah Mahmoud</creatorcontrib><creatorcontrib>Ashour, Hend</creatorcontrib><creatorcontrib>Aboulhoda, Basma Emad</creatorcontrib><creatorcontrib>Rashed, Laila Ahmed</creatorcontrib><creatorcontrib>Harb, Inas Anas</creatorcontrib><creatorcontrib>Abdelfattah, Gaber Hassan</creatorcontrib><creatorcontrib>El-Seidi, Eman Ahmed</creatorcontrib><creatorcontrib>Shawky, Heba Mohamed</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology: Gastrointestinal and liver physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ashraf, Aya Aly</au><au>Gamal, Sarah Mahmoud</au><au>Ashour, Hend</au><au>Aboulhoda, Basma Emad</au><au>Rashed, Laila Ahmed</au><au>Harb, Inas Anas</au><au>Abdelfattah, Gaber Hassan</au><au>El-Seidi, Eman Ahmed</au><au>Shawky, Heba Mohamed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations</atitle><jtitle>American journal of physiology: Gastrointestinal and liver physiology</jtitle><addtitle>Am J Physiol Gastrointest Liver Physiol</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>321</volume><issue>5</issue><spage>G461</spage><epage>G476</epage><pages>G461-G476</pages><issn>0193-1857</issn><eissn>1522-1547</eissn><abstract>Multiple theories have been proposed describing the pathogenic mechanisms of ( )-associated gastric motility disorders. We assessed ex vivo pyloric activity in -infected rats, and tried to explore the associated ghrelin hormone alteration and pyloric fibrogenesis. In addition, miR-1 was assessed in pyloric tissue samples, being recently accused of having a role in smooth muscle dysfunction. Ninety adult male Wistar albino rats were assigned into nine groups: ) control group, ) sterile broth (vehicle group), ) amoxicillin control, ) omeperazole control, ) clarithromycin control, ) triple therapy control, ) - group, ) -clarithromycin group, and ) -triple therapy group. Urease enzyme activity was applied as an indicator of infection. Ex vivo pyloric contractility was evaluated. Serum ghrelin was assessed, and histological tissue evaluation was performed. Besides, pyloric muscle miR-1 expression was measured. The immunological epithelial to mesenchymal transition (EMT) markers; transforming growth factor β (TGFβ), α-smooth muscle actin (α-SMA), and E-cadherin-3 were also evaluated. By infection, a significant ( &lt; 0.001) reduced pyloric contractility index was recorded. The miR-1 expression was decreased ( &lt; 0.001) in the infected group, associated with reduced serum ghrelin, elevated TGFβ, and α-SMA levels and reduced E-cadherin levels. Decreased miR-1 and disturbed molecular pattern were improved by treatment. In conclusion, infection was associated with reduced miR-1, epithelial to mesenchymal transition, and pyloric hypomotility. The miR-1 may be a target for further studies to assess its possible involvement in -associated pyloric dysfunction, which might help in the management of human manifestations and complications. This work is investigating functional, histopathological, and molecular changes underlying hypomotility and is correlating these with miR-1, whose disturbance is supposed to be involved in smooth muscle dysfunction and cell proliferation according to literature. Epithelial to mesenchymal transition and reduced ghrelin hormone may contribute to infection-associated hypomotility. infection was associated with reduced pyloric miR-1 expression. Targeting miR-1 could be valuable in the clinical management of pyloric hypofunction.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>34431405</pmid><doi>10.1152/ajpgi.00364.2020</doi><orcidid>https://orcid.org/0000-0001-9333-4509</orcidid><orcidid>https://orcid.org/0000-0002-5423-7228</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0193-1857
ispartof American journal of physiology: Gastrointestinal and liver physiology, 2021-11, Vol.321 (5), p.G461-G476
issn 0193-1857
1522-1547
language eng
recordid cdi_proquest_journals_2593905555
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Actin
Actins - metabolism
Amoxicillin
Animals
Anti-Bacterial Agents - pharmacology
Cadherins - metabolism
Clarithromycin
Disease Models, Animal
Drug Therapy, Combination
E-cadherin
Enzymatic activity
Epithelial-Mesenchymal Transition - drug effects
Gastric motility
Gastrointestinal Motility - drug effects
Ghrelin
Ghrelin - blood
Helicobacter Infections - drug therapy
Helicobacter Infections - metabolism
Helicobacter Infections - microbiology
Helicobacter Infections - physiopathology
Helicobacter pylori
Helicobacter pylori - pathogenicity
Infections
Male
Mesenchyme
MicroRNAs - genetics
MicroRNAs - metabolism
Muscle contraction
Muscle, Smooth - drug effects
Muscle, Smooth - metabolism
Muscle, Smooth - microbiology
Muscle, Smooth - physiopathology
Proton Pump Inhibitors - pharmacology
Pyloric muscle
Pylorus - drug effects
Pylorus - metabolism
Pylorus - microbiology
Pylorus - physiopathology
Rats
Rats, Wistar
Smooth muscle
Stomach Diseases - drug therapy
Stomach Diseases - metabolism
Stomach Diseases - microbiology
Stomach Diseases - physiopathology
Transforming Growth Factor beta - metabolism
Transforming growth factor-b
Urease
title Investigating Helicobacter pylori -related pyloric hypomotility: functional, histological, and molecular alterations
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T04%3A18%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigating%20Helicobacter%20pylori%20-related%20pyloric%20hypomotility:%20functional,%20histological,%20and%20molecular%20alterations&rft.jtitle=American%20journal%20of%20physiology:%20Gastrointestinal%20and%20liver%20physiology&rft.au=Ashraf,%20Aya%20Aly&rft.date=2021-11-01&rft.volume=321&rft.issue=5&rft.spage=G461&rft.epage=G476&rft.pages=G461-G476&rft.issn=0193-1857&rft.eissn=1522-1547&rft_id=info:doi/10.1152/ajpgi.00364.2020&rft_dat=%3Cproquest_cross%3E2593905555%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2593905555&rft_id=info:pmid/34431405&rfr_iscdi=true